Skip to main content

In this opening segment, Dr. Hauser and Dr. Fernandez discussed the FDA approval of IPX203, a new long-acting levodopa formulation for Parkinson’s disease, highlighting its significance in improving treatment options and patient compliance.:

Source: Neurology Read More